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The use of the zebrafish as an animal model alternative to mammalian
species has spawned research advancements in several medical fields1. Since the
zebrafish shares a high degree of sequence and functional homology with mammals,
studies using this organism can provide in-depth insight into host response to
disease and provide a platform for testing a range of treatment options. The optical
transparency of zebrafish at early stages of development permits easy assessment of
the effects of treatments, occurrence of tumors or other abnormal growth, disease
progression, and immune response. These characteristics make it ideal for studying
human diseases such as the Influenza A Virus (IAV). The conventional method of
IAV transmission is by aerosol, and since the zebrafish does not accommodate this
mode of entry, the virus is injected into the specimen under study.

The larvae typically require manipulation during preparatory procedures
prior to assessment, a process that can be time consuming and stressful for the
organism.
In this thesis, I describe the development of a device designed to eliminate
problems associated with manipulating zebrafish larvae by automatically
conducting specimen from a reservoir directly into an entrapment dock, where it
will be immobilized for injection and rapidly removed post-injection. This will help
to reduce the handling time of large sample sets, thereby increasing the screening
throughput. Zebrafish have fast growth rates4 hence preparatory procedures for
analysis like injection should be as quick and efficient as possible. The device uses a
system to conduct 48-72 hour old zebrafish through a liquid medium (egg water)
using a syringe pump. The complete system consists of three main subsystems,
namely the pump, optical detection and entrapment components. A 3D printed
housing encloses the electrical components of the entire system. The device works
by aspirating individual fish through a tube via a pressure gradient created with a
syringe pump. Each cycle of the device involves the following steps: (1) loading, (2)
sensing, (3) trapping, (4) injection, and (5) flushing. During loading, a single larva is
extracted from the reservoir and conducted through a tube past the optical
detection subsystem. At the sensing stage, the optical detection subsystem
composed of a photodiode and a laser, senses transmitted light from the laser and
discerns the entry of larva from air bubbles and debris with precision. Upon larva
recognition, the specimen is then conducted to the entrapment dock (step 3) where
it will be immobilized for injection (step 4). The final step (5) involves conducting

the larva out of the entrapment dock and subsequently out of entire system for
further analysis. This device will primarily serve zebrafish researchers who intend
to introduce vaccines, pathogens and other experimental materials into many
individual zebrafish larvae.
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CHAPTER 1
LITERATURE REVIEW
1.1

Influenza Virus Overview
The contagious, acute respiratory illness known as the flu has afflicted

humans for centuries, yet its precise origin remains a mystery. The working
hypothesis is that wild aquatic birds were the primary reservoir for both bird and
mammalian virus species. There is extensive evidence for the direct and indirect
transmission of influenza from birds to other species such as pigs and horses5.
Influenza viruses belong to the Orthomyxoviridae family of RNA viruses which affect
the upper and lower respiratory tract. They are spherical or filamentous and range
in size from 80 to 120 nm in diameter6,7. General symptoms of influenza include
fever, malaise, headache and cough8. The disease affects all age groups but has high

prevalence in people under 25 years and has more drastic and life threatening
effects in infants and the elderly9,7,10,11. Flu outbreaks appear suddenly and can
persist for a few days to months, if uncontrolled. The severity of an outbreak may
vary depending on the variant of influenza virus causing the disease.

1.2

Influenza Virus Variants
There are six genera within the Orthomyxoviridae virus family, and three,

Influenza A, Influenza B and Influenza C, contain viruses that can cause influenza in
humans and birds, as well as other mammals12,13. These variants are characterized
by segmented negative strand-RNA genomes that are typically enclosed in a lipid
envelope. Subtle classifications distinguish the three subfamilies. Viral surface
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proteins serve as unique identification markers for viruses, and typical surface
proteins include: a hemagglutinin (HA), which agglutinates erythrocytes and plays a
key role in viral propagation, neuraminidase (NA), which is an enzyme essential for
the release of progeny virus particles from the surface of an infected cell, and
membrane (M) proteins, which serve as ion channels.

1.2.1 Epidemiology- IAV
The most prevalent form of influenza is influenza A, which primarily affects
humans, other mammals and birds. Influenza A is a disease of immense complexity.
Its occurrence and outcome depend on interactions between the virus, which is
constantly changing its genetic and antigenic composition, and the immune system
of the host, which may not be able to respond adequately within a restricted time
frame. The principal factor determining whether influenza outbreaks occur is the
degree of complementary pairing between the surface antigens (HA and NA) of the
virus and the antibodies against them, which are in the current population7.
This class of viruses is the most lethal of the three (Influenza A, Influenza B and
Influenza C), with the ability to cause severe diseases on the pandemic scale.
Pandemics of influenza A have occurred about three times per century since
1700 and were manifested by global spread of the disease, typically with high
morbidity and mortality14. The most extreme pandemic recorded in the 20th century
was the Spanish influenza, prevalent between 1918 and 1919, with a death toll
estimated to have been between 20 and 40 million people across the globe7,14,. Other
recent notable pandemics include the 2009 avian flu (H1N1) pandemic; this virus
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was a unique combination of influenza virus genes never previously identified in
either animals or people, infecting millions and killing thousands worldwide15.
For several decades, the Centers for Disease Control and Prevention (CDC)
has made annual estimates of influenza-associated deaths, which have been used in
influenza research to develop influenza control and prevention policy. Out of the 520% of people that contract the flu in the United States each year, the CDC estimates
over 20,000 laboratory-confirmed hospitalizations annually, due to IAV and other
related complications16,17. In addition, the economy is burdened by about 87 billion
USD due to IAV related issues, ranging from medical expenses, paid work absences,
losses in productivity, decline in retail spending, and even tourism18.

1.2.2 IAV Transmission and Viral Propagation
The flu is highly contagious and infected people can spread it via aerosol to
others up to about 6 feet away. The virus spreads mainly through tiny aerosol
droplets produced when infected individuals cough, sneeze or, occasionally, just
talk. The aerosol droplets containing the virus enter the mouth, nose or respiratory
tract of people within proximity. In addition, the virus can be contracted when
people come into direct contact with surfaces and objects contaminated with the
virus and then later touch their mouth, nose, or eyes. Contaminated surfaces may
include door handles, table surfaces, banknotes, and electronic input devices like
keyboards. Research has proven that IAV can survive on such surfaces for up to
eight hours19,20,21. The flu can be contagious even before symptoms become
apparent. Most adults can infect others beginning one day before their symptoms of
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the disease are displayed and can remain contagious for up to one week after
becoming sick19. Young children with weakened immune systems, however, can be
contagious well past a week.
Upon infection, the virus replicates in the upper and lower respiratory tract,
reaching its peak at 2-3 days after infection. Symptoms of the disease start to
become apparent at this stage19. The virus induces pathologic changes throughout
the respiratory tract, with the most significant pathology occurring in the lower
respiratory tract. Bronchoscopies of persons with the flu show a diffuse
involvement of the trachea, larynx and the bronchi, with acute mucosal
inflammation and edema. The virus has an affinity for cells in the epithelial lining of
the respiratory mucosa. For viral propagation to initiate, infection of these cells
must occur. Infection begins by virus binding to the surface of the host cell, followed
by the fusion of viral and host cell membranes. The attachment and fusion is
mediated by virus hemagglutinin glycoprotein (HA) interacting and binding to sialic
acid cell receptors. Binding to sialic acid occurs via a shallow cavity near the distal
tip of the HA glycoprotein. Subsequently, influenza virus enters the cell by receptormediated endocytosis22. Since the virus has no need for DNA coding, transcription
occurs within the nucleus, followed by: replication of viral RNA and secondary
transcription, translation of viral RNA to produce viral proteins, then culminating
with the assembly of viral structural components and the release of progeny virus
into the extracellular medium.
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1.2.3 Clinical Features of Infection
In humans, influenza is characterized by the sudden onset of an acute
respiratory illness accompanied by headaches, chills and nonproductive cough. This
is usually followed by muscle aches, high fever, generalized weakness and loss of
appetite. The fever usually declines by the third day and is gone after about a week,
but the coughing and signs of weakness can persist for about two more weeks10. Due
to the virus’ nature of compromising the immune system, the host can be prone to
infection by other pathogens that can lead to further complications. Complications
of the flu can include ear infections, sinus infections, dehydration, and worsening of
chronic medical conditions such as congestive heart failure or diabetes. More severe
illnesses such as primary influenza pneumonia can develop, which can be lethal.
Secondary bacterial pneumonia, a more rare form of the disease, can also occur if
the flu goes untreated23. People over 65 years of age, those with heart conditions,
asthma, emphysema, AIDS or people receiving chemotherapy are at an increased
risk of complications from influenza.

1.3

Current IAV Research
Influenza A viruses, due to their genetic makeup and mode of propagation,

are continuously changing in several animal hosts, including birds, pigs, horses and
humans24. As a result of the rapid and constant emergence of new viral strains, IAV
is highly likely to cause human epidemics. It is, however, necessary that naturally
occurring IAV should be monitored and characterized to improve the current
understanding of the host tropism as well as the virulence of IAV. There have been
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numerous research advancements in IAV research in the past few decades, some of
which include, but are not limited to: viral/human surveillance and characterization,
influenza genome diversity of evolution, vaccination technologies, tissue pathology
and influenza animal model manipulation technologies24,25,26,27,28,29,30. The National
Institute of Allergy and Infectious Disease (NIAID) Influenza Research Program
supports research to learn more about the structure and pathogenesis of influenza
viruses. Such research has proven to be invaluable to the development of new
vaccines, therapeutics, and diagnostics31. Current research involves understanding
viral replication, the emergence of new viral strains and the effect those have on the
immune system. A major NIAID activity is the Influenza Genome Sequencing Project.
This is a joint effort to obtain complete genetic footprints of thousands of human
and avian influenza strains, with the goal of providing valuable genomic knowledge
that can be used to create improved public health countermeasures. As of May 2014,
more than 16,000 human and avian isolates have been completely sequenced and
made publicly available32.
NIAID also supports the research community by developing new animal
models for preclinical evaluation of vaccine and therapeutic candidates. Animal
models are useful tools that serve as biological resources for microarrays, clones,
peptides, and reagents.

1.4

Animal Models
Animal models have been pivotal in research for decades, leading to major

drug discoveries and medical breakthroughs33,34. Suitable models are usually
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selected based on physiological, anatomical and genetic resemblance with humans.
The unlimited supply and ease of manipulation are some of the general advantages
of animal models. Scientific research can sometimes involve statistical analysis of
test specimens, mostly by manipulating only one variable while keeping others
constant, and then observing the consequences of that change. An adequate number
of test specimens are, however, required to accomplish this task effectively. The
relative ease of manipulating large sample sizes makes animal models invaluable to
medical research.
Rodents are the most common type of mammal used in experimental studies.
Extensive research has been conducted using rats, mice, gerbils, guinea pigs, and
hamsters35,36. Among these rodents, the majority of genetic studies, especially those
involving disease, have employed mice because their genomes are similar to that of
humans and many unique strains have been developed. Other common
experimental organisms include fruit flies, baker's yeast and zebrafish37.

1.4.1 Zebrafish as An Influenza A Virus Model
Animal models of influenza are essential to research that focuses on gaining a
better understanding of the virus and its effect on humans. There are currently
various research applications of animal models ranging from the pathogenesis and
host response to IAV to antiviral drug screenings and pre-clinical testing of antiviral
drugs and vaccines. IAV animal models are also used to investigate the competency
of vaccines and drugs to combat the virus, prevent future complications and
commonly, to reduce the symptoms of influenza. In selecting the models for
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research, a couple of factors have to be considered. The most important criterion is
the susceptibility of the animal to influenza virus infection while supporting viral
replication, and exhibiting human histopathological and morphological symptoms of
an influenza virus infection38.
Zebrafish (Danio rerio) models for infectious diseases are well established for
characterization of bacterial, fungal and viral infections 39,40,41. The National
Institutes of Health (NIH) along with other research bodies has approved the
zebrafish animal model for use in the advancement of biomedical studies. Some of
its inherent advantages, such as optical transparency, minimal husbandry, large
clutch size and fast reproductive cycle make the zebrafish an ideal specimen for
high-throughput drug testing. Another important factor to consider is that zebrafish
are propagated at the optimal incubation temperature for viruses during infection
studies. Zebrafish can be grown in a temperature range within that of the human
respiratory tract (from 25 to 33°C).
As a result, the zebrafish might be well suited to modeling human respiratory viral
infections, given the similarities between the zebrafish swim bladder and the human
lung42,43,44,45. There have also been recent studies of zebrafish swim bladder
infections with human fungal pathogens. Furthermore, zebrafish at the early stage
of development are highly amenable to genetic manipulation and transgenesis2.
Among all of the benefits of the zebrafish animal model system, one of the
most important characteristics that make this system ideal for IAV research is the
zebrafish’s immune system. During the onset of development, zebrafish are known
to rely solely on the innate immune response for the first 4 to 6 weeks46,47,48.
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Hematopoiesis in zebrafish produces largely the same differentiated cell types as
observed in mammals. Monocytes, neutrophils, macrophages and eosinophils have
all been described within the zebrafish myeloid lineage47. In addition, other cells
with mammalian cytotoxic properties, such as mast cells and natural killer cells,
have also been classified within zebrafish49. The innate immune functions of these
cells provide an effective defense system during the early stages of development50.
The majority of the research conducted using the zebrafish model involves
fish-specific viral pathogens that have the ability to infect and cause disease;
however, few human viruses have been demonstrated to infect the zebrafish51.
Some recent studies have proven the zebrafish to be susceptible to viral infection by
mammalian viruses, as characterized by Burgos et al, where the zebrafish was used
as a model of herpes simplex virus type 1 (HSV-1) infection of the nervous system52.
Gabor et al, at the University of Maine described a zebrafish model for human
influenza A Virus (IAV) infection and showed that zebrafish embryos are susceptible
to infection with both influenza A strains APR8 and X-31 (Aichi). Influenza-infected
zebrafish showed an increase in viral burden and mortality over time. The
expression of innate antiviral genes, the gross pathology and the histopathology in
infected zebrafish recapitulate clinical symptoms of influenza infections in humans2.
The study was conducted based on the premise that an antiviral state similar to that
in humans was induced in infected specimens, leading to the deduction that
zebrafish can be a suitable alternative to vertebrate animal models used for IAV
studies. Recombinant influenza viruses carrying a GFP reporter gene in the NS
segment (NS1-GFP) were used to characterize infection in the zebrafish. Although
9

attenuated compared to the wild type virus, it is typical for these modified viral
strains to replicate efficiently53. To determine whether the modified human isolates
of IAV could cause disease in zebrafish embryos, different strains of IAV [APR8
(H1N1) and X-31 (H3N2)] were injected intravenously into 48 hpf (hours post
fertilization) zebrafish through the Duct of Cuvier to mimic viral infection in the
human blood stream. An inert phosphate buffered saline solution was also injected
into a number of zebrafish embryos in a control setup2.
Data from the study demonstrated that IAV replicates within zebrafish and
suggests that the death of IAV-infected zebrafish is likely to be caused by IAV
infection. To investigate the effect of treatment on the zebrafish immune system, an
antiviral compound used for the treatment of IAV in humans was introduced, which
reduced the mortality of the infected fish as well as the virulence of IAV.

1.4.2 Pathological Phenotype Observed in IAV Infected Zebrafish
In an effort to characterize the innate immune response of zebrafish to the
presence of either strain of IAV (APR8 or X-31) in the bloodstream, infected
embryos were monitored over time for behavioral and phenotypic changes2. A
controlled set of embryos were injected with PBS (phosphate-buffered saline) and
monitored under identical conditions. While fish in the control setup displayed no
abnormal behavior or signs of viremia, the IAV-injected zebrafish exhibited
symptoms of lethargy, with signs of edema observed in the pericardium and yolk
sac. Furthermore, the edema worsened over time and additional pathological
phenotypes, including varying degrees of lordotic curvature of the spine, were
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observed. Other observations included pigmentation defects, cranial irregularities
and eye deformities.
Gabor et al extended the investigation to further characterize the innate
immune response of zebrafish to IAV infection by conducting pathological analysis
on the cellular level. Influenza virus typically replicates in the epithelial cells
throughout the respiratory tract of humans and, the virus can be recovered from
both the upper and lower respiratory tract of individuals who have been naturally
or experimentally infected. IAV viremia in its acute stage can be characterized by
multifocal destruction and desquamation of the pseudostratified columnar
epithelium of the trachea and bronchi29. It is also typical for the basal layer of the
epithelium to be the only structure remaining. Edema and congestion of the
submucosa can also be observed.
In the case of the zebrafish, Gabor et al. prepared tissue samples from IAV infected
zebrafish 48 after injection. Analysis of the tissues confirmed the clinical symptoms
of influenza, including necrotic tissues and edema.

1.5

Systemic IAV Infection
The vascular system allows the flow of blood from the heart to all parts of the

body, supplying oxygen to the most vital organs such as the kidneys, the brain and
the liver. Since blood within this system is distributed throughout the body from
the aorta, introduction of a blood borne pathogen such as IAV into the vasculature
expedites viral infection throughout the body. IAV is characterized by hemagglutinin
(HA), an antigenic glycoprotein usually found on their surfaces. These glycoproteins
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are responsible for binding the virus to the cell that is being infected54. The viral
hemagglutinin proteins bind to sialic acid groups of cellular surface glycoproteins to
achieve viral attachment and entry. The specificity of the HA-Sialic binding complex
is one of the major determinants for controlling viral tropism and host specificity
This explains why some organisms are susceptible to certain disease-causing
pathogens, while others are not.
Typically, human influenza viruses have a binding preference for α2,6-linked
sialic acid. Avian influenza virus, on the other hand, binds to the α2,3-linked sialic
acid of the host bird56. Besides the conventional viral infection mechanism, the virus
can sometimes travel to acidic endosomes for membrane fusion via clathrin or
caveolin mediated endocytosis57. Alternate pathways into the cell by viruses have
also been studied, demonstrating that influenza viruses have the ability to employ
different cell entry mechanisms to achieve viral infection. It is, however, not known
whether all influenza viruses have the ability to use the other various pathways with
identical preferences 56, 58, 59, 60. Following the interaction between the viral HA and
the α2,6-linked sialic acid, endocytosis of the viral particle is triggered. Figure 1
demonstrates a typical process of cell entry of two different viruses: Influenza and
HIV.
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Schematic diagrams of HIV-1 and influenza virus fusion and entry processes. Major
conformational changes in the viral envelope glycoproteins occur for fusion of both HIV-1 and influenza
virus, but the requirements for fusion differ, as do the viral target types (not shown). For HIV-1, gp120
binds sequentially to its primary receptor CD4 and, after an initial conformational change, to coreceptors (chemokine receptor) CCR5 or CXCR4 (not shown) (step 1a). Co-receptor interaction triggers
fusion of the viral and cellular membranes, initiated by the HIV-1 fusion peptide that is located in gp41
(step 2a). Fusion and entry of the HIV-1 genomic RNA and accompanying viral proteins into the target
cell occurs at the cell surface at neutral pH. Following entry, the HIV-1 RNA genomes are transcribed by
reverse transcriptase into DNA (step 3a) and the HIV-1 pre-integration complex is transported to the
nucleus for integration into target cell genomic DNA to initiate chronic infection. On different cell types
from those affected by HIV-1, influenza virus binds via haemagglutinin 1 (HA1) to terminal sialic acids
present on glycoproteins or on glycolipids (step 1b). The virus is subsequently internalized by receptormediated endocytosis into a low pH compartment (endosome), triggering conformational changes that
expose the viral fusion peptide that is located in HA2 (step 2b). Subsequently, the genomic
ribonucleoprotein complex is transported to the nucleus to initiate transcription and replication of the
viral genome (step 3b).

Figure 1: Process of influenza virus infection.
Karlsson et al. Schematic diagrams of HIV-1 and influenza virus fusion and entry
processes. Diagram. The challenges of eliciting neutralizing antibodies to HIV-1 and to
influenza virus. Fall 2008; 6(2): 148. Available from Nature Reviews Microbiology.
Accessed May 6 2017.
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Influenza virus binds to terminal sialic acids present on glycoproteins or
glycolipids via HA1. The virus is subsequently internalized by receptor-mediated
endocytosis into an endosome. This initiates conformational changes that expose
the viral fusion peptide located on HA2. The entire viral protein complex is then
transported to the nucleus, where transcription and replication of the viral genome
will occur
Replication and translation of the viral RNA produces new viral
macromolecules, which are ultimately assembled into complete viral particles for
release and infection of new cells62.

1.5.1 α 2,6-linked Sialic Acids in Zebrafish
The presence of compatible sialic acid modifications on host glycolipids or
glycoproteins is one of the main determinants of viral infection in most animal
species. The presence of α 2,6-linked sialic acid in the zebrafish makes this a
valuable model system for the study of the influenza A virus. In spite of this, there
are no known reported naturally occurring viral infections of the zebrafish63. In an
effort to determine whether zebrafish embryos could serve as a host for infection
with mammalian/human isolates of IAV, Gabor conducted a study to analyze the
sialic acid linkage types present on zebrafish glycoproteins or glycolipids2. Analysis
using High Performance Anion Exchange Chromatography with Pulsed
Amperometric Detection (HPAEC-PAD) demonstrated that α 2,6-linked sialic acids
were present in zebrafish embryos two days after fertilization. There were,
however, no α 2,3-linked sialic acids detected in the two day-old embryos2. There
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are a number of chemical variants of sialic acids, and influenza strains vary in their
affinity for them. Terminally linked sialic acids can occur in α-2,3, α-2,6, or α-2,8
linkages. Even though the study was not intended to identify α 2,8-linked sialic
acids, others have previously demonstrated that zebrafish have the ability to
synthesize a variety of sialylated glycoconjugates during the onset of their
development 64,65,66. These unique characteristics of the zebrafish model system
make it an attractive candidate for studying infectious viral diseases. With further
studies into sialylated glycoconjugates present at various stages of development of
the zebrafish, additional human viral diseases can further be characterized. Some of
the known human viral pathogens that have an affinity for α 2,6-linked sialic acids
include certain members of the following virus families:
coronaviridae, paramyxoviridae, caliciviridae, picornaviridae, reoviridae, polyomavi
ridae, adenoviridae and parvoviridae. Most of these groups contain major pathogens
for humans that affect all parts of the body, ranging from small organs like the
salivary gland (in the case of mumps) to cellular networks as intricate as the
immune system2,67,68.
Avian influenza virus strains have the tendency to bind to sialic acids
attached to galactose via an α 2,3-linkage, which is the major sialic acid on epithelial
cells of the duck gut. Ciliated epithelial cells in the human trachea lack α 2,3 linked
sialic acids, suggesting that the lack of a suitable receptor accounts for the inefficient
replication of certain human viruses in duck intestine and of certain avian viruses in
humans 55,69.
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1.6

Zebrafish Antiviral Defenses
Although the zebrafish animal model has been proven effective for testing

medical treatments and virological assays, it can serve as an ideal tool for
understanding host biological responses after viral infections, particularly the
Influenza A virus. A clear and thorough understanding of a host’s immunity (both
innate and adaptive) can provide insight into new treatments and effective
therapies. The zebrafish, like many organisms possesses innate and adaptive
immunity, however the zebrafish relies solely on its innate immune response
system for the fist 4-6 weeks of development2. Within this period of growth,
zebrafish develop from the embryo to the larvae stage. This temporal separation of
innate and adaptive immunity in zebrafish allows for the study of the innate
immune response to viral infection independent of adaptive immunity. Upon viral
attack, one of the primary processes initiated is the induction of host antiviral state,
which slows down the rate of progression of viremia2. The major molecule
responsible for the antiviral state is interferon (IFN). Cells that are already infected
with a virus secrete interferons to prevent further virus exposure of healthy cells.
Response to IFN involves a rapid and direct signal transduction mechanism that
quickly reports the presence of extracellular cytokines to the cell nucleus. This
preserves the specificity inherent in cytokine-receptor interactions to induce
expression of a set of genes via transcription, leading to encoding of important
antiviral proteins. Establishment of the resulting antiviral state provides a crucial
initial line of defense against viral infection. Studies of IFN-deficient cells and
animals derived by gene targeting have demonstrated the essential nature of IFN-
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mediated innate immunity 70,71,72.
All blood cells in humans begin as hematopoietic stem cells, and then differentiate
into myeloid cells (erythrocytes, megakaryocytes, monocytes, neutrophils,
basophils, or eosinophils) or lymphoid cells (T-lymphocytes and B-lymphocytes).
These immune cells typically perceive and respond to microbial stimuli. Zebrafish
are largely similar to humans with respect to cell differentiation. They have distinct
stages of hematopoiesis that occur in discrete yet functionally analogous sites.
Zebrafish myeloid lineages, including monocytes, macrophages, neutrophils and
eosinophils, have been reviewed and have been characterized as similar to those in
humans 47. The innate immune roles of these cells offer an efficient defense
mechanism during the onset of development. In the case of a viral infection such as
influenza, the immune cells are triggered and function accordingly to quarantine the
virus by inducing the antiviral state. Macrophages and neutrophils (large, mobile
phagocytic cells) can also be recruited to the site of infection to engulf invading
species. Macrophages have been known to respond more quickly to infection than
neutrophils at about 30hpf73. The relatively slower neutrophils respond at about
52hpf to complement activities of the macrophages, partly because the phagocytic
capability of neutrophils is relatively low compared to that of macrophages74.
Precursors of the lymphoid cells (T-cell and B-cells) begin the process of
rearrangement and recombination of the genes for immunoglobulin and T cell
receptor molecules by day 4. This is the onset of adaptive immune system
development. The thymus, which is also a lymphoid organ, produces T cells and B
cells for the zebrafish immune system, the pancreas has also been reported to
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produce B cells75,76. Even though the adaptive immune system begins forming early
in zebrafish development, studies have shown that the zebrafish as incapable of
mounting a full antibody response until early adulthood, which is about 4 weeks
post fertilization. The mode of pathogenic defense up until this point is exclusively
dependent on the innate immune system77.
In an effort to understand the different maturation states of the immune
system during zebrafish development, S.H. Lam et al investigated the expression of
six immune-related genes of the zebrafish namely: Ikaros, that encodes a
transcription factor which is used as an early lymphoid marker; Rag-1
(Recombination activating gene-1), which encodes a protein involved in genomic
rearrangement of the T-cell receptor, immunoglobulin loci, and is a suitable marker
for maturing lymphocytes; T-cell Receptor Alpha Constant region genes (TCRAC)
which encode portions of the antigen receptors of mature T-lymphocytes; three
immunoglobulin light chain constant region genes (IgLC) which encode portions of
the antigen receptors of mature B lymphocytes. Although there have been cloning
and characterization studies on immune-related genes prior to this study78,79, there
was very little known about the maturation of the zebrafish immune system with
regard to its form and function. By employing standard profiling techniques to
assess gene expression (quantitative real-time polymerase chain reaction, in situ
hybridization (ISH), immuno-affinity purification and Western blotting), Ikaros was
detected first, at 1 dpf. The expression thereafter increased gradually to more than
two-fold between 28 and 42 dpf before decreasing to less than the initial 1dpf
expression level in adult fish (aged 105 dpf). Rag-1 expression levels increased
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rapidly (by 10-fold) between 3 and 17 dpf, reaching a maximum between 21 and 28
dpf before decreasing gradually. In adult fish aged 105 dpf however, the expression
level of Rag-1 dropped significantly, and was equivalent to the expression level at 3
dpf. T-cell receptor alpha constant region genes and mRNAs of immunoglobulin
light chain constant region (IgLC) isotype-1, 2 and 3 were detected at low levels by 3
dpf and their expression levels increased steadily to the adult range between 4 and
6 weeks post-fertilization (wpf). Using tissue-section ISH, Rag-1 expression was
detected in head kidney by 2 wpf while IgLC-1, 2 and 3 were detected in the head
kidney and the thymus by 3 wpf onwards. Secreted Ig was only detectable using
immuno-affinity purification and Western blotting by 4 wpf. A humoral response to
T-independent antigen (formalin-killed Aeromonas hydrophila) and T-dependent
antigen (human gamma globulin) was observed in zebrafish that were immunized at
4 and 6 wpf, respectively, indicating a normal immune response. The findings
revealed that the zebrafish immune system is morphologically and functionally
mature by 4–6 wpf77.

1.7

Injection of Zebrafish Embryos
One of the most common techniques used to introduce materials into

zebrafish embryos and larvae is injection. Although invasive, it allows precise
targeting of tissues and organs. When conducted under appropriate conditions, such
as mild sedation, injections pose minimal risk to zebrafish larvae. During injection,
certain substances such as nucleic acids, proteins, or drugs are introduced into the
zebrafish, usually at the early stages of development80. Injections are typically
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conducted with glass needles filled with the material to be delivered. The glass
needles can be fabricated easily by carefully drawing out a heated capillary tube
with the appropriate inner and outer diameter81. The glass needles are then held by
a micromanipulator that controls and changes the position of the needle relative to
the embryo with high precision. Pressure from compressed air is used to release the
content into the embryo or larva.

Figure 2: A typical micromanipulator for manual injection needle operation in all
three axes (x, y and z). It allows for coarse adjustment readings with an accuracy of
100 micrometers. Warner Instruments, Model MM-33, Hamden CT.
Injection allows rapid delivery of material into the zebrafish. After manipulation of
embryos or larvae into a suitable array, an experienced researcher can inject several
hundred embryos in one hour, although the relatively high chances of error
associated with this technique, can negatively affect the consistency of injection. A
detailed injection protocol consisting of zebrafish loading and preparation has been
characterized82.
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1.7.1 Standard Techniques
Injection of zebrafish has been commonplace for decades and numerous
procedures have been developed to inject almost every part of the live fish, notably
the brain ventricle, the kidney, the swim bladder and the Duct of Cuvier (DC). The
DC is a wide blood circulation valley on the yolk sac connecting the heart to the
trunk vasculature. Injection through this duct allows quick and efficient systemic
infection of zebrafish and is particularly useful for introduction of bacteria into
embryos between 1 and 3 dpf. For these injections, the needle is inserted into the
starting point of the duct of Cuvier just dorsal to the location where the duct starts
broadening over the yolk sac. This location is the deepest section of the duct and
therefore provides the lowest risk of puncturing the yolk sac. The injected material
will follow the blood flow through the duct of Cuvier, over the yolk sac toward the
heart, and can be monitored directly post-injection by monitoring the expanding
volume of the duct83.

1.7.2 Rapid Prototyping and Influence of Technology on Research
Ranges of technological advancements have paved the way for new and
innovative devices and techniques that help make laboratory work more efficient
and reliable. The rate of technological advancement has been high within this past
decade, which may be attributable in part to the increase in computational power 84.
Another major influence on technological advancement is the emergence of 3D
printing technologies for rapid prototyping, which is poised to revolutionize device
development in many industries, including healthcare. Since its initial use, additive
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prototyping technology has advanced to use in a wide range of applications
including tissue engineering, dentistry, construction, automotive and aerospace
85,84,86.

The technology is already changing the way objects are made, with resulting

products ranging from tools and toys to clothing and even body parts. 3D printing is
part of a process known as additive manufacturing where an object is created by
adding material layer by layer, usually at a fraction of the cost and time of standard
means such as forging, molding and sculpting. In the medical world, physicians are
testing biomaterials for regenerative medicine. Using medical imaging and 3Dmodeling technology, surgical teams can now also use 3D printers to create
temporary tools that are affixed to the skeletal structure of the patient to provide a
precise "blueprint" for reshaping bone structure to perfectly accommodate
standard-size implants. Custom-printed drilling guides permit screws to be placed
precisely to ensure the best fit with a patient's body87,88.
Within the dynamic branch of zebrafish research, prototyping technologies
are gradually being introduced to improve the speed and quality of lab work30,92,97.
These technologies may have the potential to make complex and tedious
procedures, such as injection and imaging of chorionated embryos, relatively simple.
The following paragraph highlights devices that implement rapid prototyping
techniques to make working with zebrafish more efficient.

1.7.3 Notable Devices for Zebrafish Injection
Pardo-Martin et al. at Massachusetts Institute of Technology and Harvard
University developed a high-throughput platform for cellular-resolution in vivo
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pharmaceutical and genetic screens in zebrafish larvae30. The automated system is
capable of sampling zebrafish larvae and then positioning them for imaging. The
system is also capable of manipulating both superficial and deep organs (via
femtosecond laser microsurgery). Each cycle of the system includes the following
steps: loading, sensing, trapping, injection and flushing. During loading, the system
extracts larvae from a reservoir filled with distilled water. A high-speed optical
detection system composed of a photodiode and two LEDs detects the entry of
larvae into the loading tube. The photodiode senses transmitted and scattered light
from the laser light source. By monitoring the light signals, the system can
distinguish a larva from air bubbles and debris with 99.99% reliability (n = 100).
After loading and detection, the larva moves into a capillary positioned within the
angle of view of an optical imaging and manipulation system. Using a fast camera
and an automated image-processing algorithm, the larva is coarsely positioned by
the syringe pump within focus of the optical imaging system. At the end of one
complete cycle, animals can be dispensed back into either individual wells or larger
containers by executing the loading process in reverse. While this device boasts of
effortless zebrafish manipulation for imaging, it falls short of addressing the tedious
process of microinjection: a frequent and necessary step prior to imaging. Design of
an entrapment mechanism as part of a sampling device to accommodate an injection
needle would add an important manipulation capability.
Rohde et al at Massachusetts Institute of Technology developed a high-speed
microfluidic sorter with the ability to isolate and immobilize small live animals in a
well-defined geometry (within a chip) for screening phenotypic features in
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physiologically active animals. The integrated chip contains individually
addressable chambers that can be used for incubation and exposure of individual
animals to biological compounds and high resolution imaging without the need for
anesthesia. Besides its sorting and immobilizing function, the channels within the
microfluidic chip can be combined in various configurations to permit a multitude of
complex functions such as small animal incubation (eg. C. elegans), immobilization
and independent subcellular resolution imaging89. This system is versatile but
shares a similar limitation with the system made by Pardo-Martin30 and his team: it
does not address the upstream procedure of animal injection. Furthermore, the high
multifunctional capabilities of this system might make it susceptible to crosscontamination during use. Both the mechanical and electrical complexity of the
system also raises durability concerns.
Bischel et al at University of Wisconsin-Madison designed a zebrafish
entrapment device that can be used to quickly and repeatedly position zebrafish
embryos in a predictable array with the help of a pipette. The Zebrafish Entrapment
by Restriction Array (ZEBRA) is well suited for use with automated microscope
stages, thereby reducing the amount of imaging time and further increasing
throughput compared to traditional methods. ZEBRA was designed and optimized
to immobilize 3–5 dpf zebrafish embryos in a predictable array without the use of
agarose. The device consists of an enclosed channel with a restriction width that is
accessed through an input and an output port90. For normal function, ZEBRA must
be filled with water (this process requires oxygen-plasma treatment to render the
inside of the channels hydrophilic). After initial filling, a pipette can be used to add a
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droplet of water containing a selected zebrafish embryo to the input port of the
device. The main function of the device is governed by passive pumping: a
phenomenon by which surface tension induces pressure differences to drive fluid
movement in closed channels91. As a result, water is driven from the smaller input
port (with higher surface tension) to the larger output port (with lower surface
tension). The zebrafish is then trapped in place upon reaching the channel
restriction. Users can choose whether to load the zebrafish into the device headfirst
or tail-first depending on the desired application. Passive pumping works
reproducibly as long as there is a closed channel between an inlet and an outlet91.
This makes the device more practical and portable since it is not dependent on a
power source. Despite its inherent advantages, the device does not accommodate
zebrafish injection. The flow rate and aspiration conditions within the channels
appear to be dependent on the size of the droplet placed at the inlet of the device. As
the droplet collapses, the aspiration rate decreases thus creating a device constraint
that can potentially limit the length of the channel between the inlet and the outlet
ports91. Although less energy-efficient, employing active pumping in this scenario
can potentially eliminate this constraint to permit longer channels that can
accommodate zebrafish, as well as other animals, such as C. elegans.
Westhoff et al at University of Heidelberg formed a piece of brass to serve as
a negative mold to cast agarose to yield a series of wells capable of holding zebrafish
for imaging and micromanipulation92. The brass mold casts indentations into an
agarose gel by inserting the tips of the mold into unset agar solution and allowing
the solution to gel. The mold is removed, leaving voids that are contoured to hold
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zebrafish larvae for imaging. While this device requires significant manual
interfacing, it minimizes the issue of having to insert and orient specimens in an
agar medium. Users simply pipette their specimen into the wells prior to imaging.
Evenly spaced wells allow screening of large numbers of specimens and can be
automated with a translation stage. While the device offers a simple way for users to
probe and organize large quantities of specimens, it leaves little room for
automation of trans-locating fish into the device. As a result, more user interaction is
needed to move and organize the specimens. Automating this process would allow
for minimal user interaction between the user and the device.
The devices discussed above all demonstrate innovative approaches to
eliminating common problems of working with zebrafish, such as manipulation;
however, none of them is applicable to the principal function of zebrafish injection.
Using the zebrafish as an animal model for IAV studies involves systematically and
reliably introducing the virus into individual larvae via injection. A device to
conduct and immobilize zebrafish specimens for injection will be invaluable to IAV
studies, particularly where sample sizes are very large. This project has been
directed toward design and fabrication of an automated device that will help solve
this problem. The main goal of the proposed device is to provide a means for
storing and gently conducting zebrafish from a reservoir to a chamber for
immobilization and injection. This will minimize direct interaction between the user
and specimen, with the goal of reducing injection/handling time in experiments and
to maximize reliability and laboratory efficiency, as well as to minimize long-term
costs.
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CHAPTER 2
METHODS
2.1

Overview
The device employs a system to conduct 48-72 hour old zebrafish through a

liquid medium (egg water) using a syringe pump. The complete system consists of
three main subsystems namely the pump, optical detection and entrapment
components. The device works by aspirating individual fish through a tube via a
pressure gradient created with a syringe pump. Each cycle of the device involves the
following steps: (1) loading, (2) sensing, (3) trapping, (4) injection and (5) flushing.
During loading, a single larva is extracted from the reservoir and conducted through
a tube past the optical detection subsystem. At the sensing stage, the optical
detection subsystem composed of a photodiode and a laser, senses transmitted light
from the laser and discerns the entry of larva from air bubbles and debris with
precision. Upon larva recognition, the specimen is then conducted to the
entrapment dock (step 3) where it will be immobilized for injection (step 4). The
final step (5) involves conducting the larva out of the entrapment dock and
subsequently out of entire system for further analysis. The syringe pump is preprogrammed and manipulated with LabView, the control software. This device will
primarily serve IAV researchers who intend to introduce vaccines, pathogens and
other experimental materials into many individual zebrafish larvae.
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Figure 3: Device schematic and design. The device offers minimal interaction and
seamless aspiration of zebrafish specimen, ultimately trapping and immobilizing it for
microinjection of biomaterials.
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The following sections describe in detail the design and construction of the
device components.

2.2

Pump Subunit Components

Figure 4: An image of the input reservoir. The assembled reservoir is shown in Figure
4.1; Figure 4.2 and Figure 4.3 show the design renderings of the top and bottom
reservoir caps, respectively.
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The device pictured above serves as the entry point of the zebrafish
specimen into the device. With a maximum internal volume of 60mL, the reservoir is
capable of accommodating about 50 individual 48-72 hpf larvae. When filled with
egg water (Figure 4.1), the unique shape and design allows enough room for the fish
to swim and eventually be removed by suction through the outlet tube positioned
along the wall of the reservoir’s bottom cap. During testing, it was observed that the
zebrafish larvae had the tendency to sink downward, toward the deepest part of the
bottom cap. This made it difficult for specimen to be randomly removed from the
reservoir through the tube, thus dramatically reducing the larvae output rate. To
remedy the problem, a bubbler was introduced. A narrow hole was drilled through
the deepest part of the bottom cap to allow for a silicone tube to be threaded
through and connected to the bubbler. An Aqua Culture single outlet aquarium air
pump was used as the air source Figure 5. It includes a check valve that prevents
the siphoning of reservoir water into the air pump in the event of a power loss.

Figure 5: Aqua Culture single outlet aquarium air pump. The pump is originally an air
pump designed for a 5- to 15-gallon aquarium. It includes a check valve (blue valve
pictured) that can help prevent the siphoning of reservoir water into the air pump in
the event of a power loss.
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Pressure is provided to the system with a New Era NE-1000X Bidirectional
Syringe Pump. The pump supplies negative pressure (withdraw mode) for a brief
period to cause specimen to be withdrawn from the reservoir and into the system
where it will be sensed by the laser diode/photodiode photodetection system. The
pump then switches to positive pressure (infuse mode) to allow the specimen to
advance through the system.

Figure 6: New Era NE-1000X bidirectional programmable syringe pump. With fully
programmable and stand-alone capabilities, the pump can be programmed for up to
41 pumping phases that change pumping rates, set dispensing volumes, insert pauses,
control and respond to external signals. It has a dispensing accuracy of ± 1%.

2.3

Optical Detection Subunit Components
The optical detection unit helps with the direction of travel of specimen

within the system by sensing the presence of zebrafish, which prompts the syringe
pump to switch between supplying positive and negative pressure. The two main
elements used for sensing are: a 5mm transparent cylinder head photodiode (PD)
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(LLSO5-A, Senba Optical Electrical Co., Ltd) and a 4.5V 650 nm red laser diode
module (#01444878, LightInTheBox Co., Ltd). During normal operation, the red
laser beam is focused onto the photodiode and a base (unobstructed) voltage
reading is observed and recorded (voltage comparator circuit yields a HIGH signal).
The movement of specimen past the light beam reduces the voltage reading,
resulting in the voltage comparator circuit producing a LOW signal, indicating the
presence of a larva as depicted in the cartoon (Figure 7.1).
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Figure 7: An image of the optical detection unit components. Figure 7.1 depicts a
cartoon that highlights a zebrafish larva moving past the red laser beam to indicate
the presence of a specimen; the blue selection within Figure 7.2 shows the actual setup
of the detection system mounted on a 3D printed harness.
2.4

Entrapment Dock
A critical component of the injection system is the entrapment dock, a device

that immobilizes the specimen for injection. The dock was designed using SolidEdge
rapid-prototyping software and 3D printed using a transparent photopolymer that
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provides a suitable level of surface smoothness. The polymer (VeroClear-RGD810)
is a rigid, nearly colorless material with dimensional stability for general purpose,
fine-detail model building and visual simulation of transparent thermoplastics. The
entrapment dock dimensions are represented in Figure 8.

Figure 8: Image of the entrapment dock with highlighted channels and dimensions in
millimeters.
The channels within the dock are designed to accommodate the shape of a 2day old zebrafish larva. Beginning from one end of the dock, the channel begins with
a 1mm diameter opening to accommodate the capillary tube from the automated
delivery system. It then narrows to a micro-constriction that is small enough to
allow some excess water to flow past the specimen to the other end of the dock
while simultaneously trapping and immobilizing the specimen for injection. An
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opening perpendicular to the trapped specimen serves as an entry for the injection
needle.
Despite the convenience and practicality of 3D printing, the ability to
fabricate small, intricate designs such as microchannels can sometimes be limited.
Although printers and techniques exist for micro fabrication, the cost of securing a
high-resolution printing unit is high, with prices starting at 20,000 USD. Less
expensive units can perform similar functions to the more expensive machines, but
with less precision. The lab in which the entrapment dock was printed (Innovative
Media Research & Commercialization Center, University of Maine) was equipped
with an intermediate resolution 3D printer (Stratasys Objet30, SUP 705 support
material), and so several challenges influenced the final design of the port. Most
notable amongst these was the problem of lodged support material within the
microchannels. Most 3D printers employ the Additive Manufacturing (AM) design
technique where successive layers of material are formed under computer control
to create an object; it is analogous to building a brick wall layer by layer. If a
particular design is supposed to have an enclosed opening or channel, support
material is deposited into the cavities to hold up the structure as the rest of the
object is being built. As a result of this process, all of the entrapment docks were
filled with support material and post-printing procedures to remove it proved futile.
Some of the procedures used were: applying mild heat, using biodegradable
solvents and manual excavation of the material using a thin syringe needle. These
problems spawned the idea of bisecting the original design of the port horizontally
and printing both pieces independently, as displayed in Figure 9.2. This exposes the
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channels and allows for easy removal of the support material without damaging the
integrity of the channels. A supporting harness was later designed and 3D printed to
rejoin and clamp together the pieces of entrapment dock Figure 9.3.
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Figure 9: Images of the entrapment dock and its supporting components designed
using Solid Edge CAD software. The 3D printed solid is a transparent material
(VeroClear-RGD810) that provides dimensional stability and a rigid finish. Figure 9.1 is
an image of the assembled entrapment dock; Figure 9.2 depicts the two split-pieces of
the entrapment dock; Figure 9.3 shows the rendering of the supporting harness that
clamps and keeps the split-pieces in place; Figure 9.4 shows the rending of the
completely assembled device with the entrapment dock highlighted in green; Figure
9.5 is an image of the completely assembled device.
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2.4.1 Biocompatibility
3D printing and photopolymer composition have improved tremendously
within the past few years, and problems with biocompatibility have mostly been
overcome by post-processing the 3D printed device and optimizing the chemistry of
the resins used to create micro- and milli-fluidic platforms. The polymer used to
print the entrapment dock (VeroClear-RGD810) is dimensionally stable and is
approved for medical applications93. In future pursuits to perfect the entrapment
dock and to accommodate different organisms, an advanced polymer (MED610,
made by Stratasys) could be used. This plastic has a wider biocompatibility range
and might serve as a better alternative94.
Macdonald et.al at the University of Glasgow assessed the biocompatibility of
four commercially available 3D printing polymers (VisiJetCrystal EX200, Watershed
11122XC, Fototec SLA 7150 Clear and ABSplus P-430) with zebrafish and observed
the key developmental markers in the developing embryos. Their results showed
that the four photopolymers were very toxic to the embryos, resulting in fatality in
most cases95. These results re-emphasize the importance of using biocompatible
materials to achieve reliable results, especially when conducting experiments in
which morphological changes are analyzed. It is becoming widely acknowledged
that more detailed biocompatibility testing must be provided by manufacturers
before 3D printed objects are used in different biosystems96,97.
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2.5

Specifications and Parameters

1.

The 48-72 hpf zebrafish larvae can be aspirated up to a maximum flow rate
of 330mm3 s-1, given tubing dimensions of 0.8mm inner diameter x 2.4mm
outer diameter.

2.

The maximum speed the larvae can attain in this tubing without deformation
is 656mm s-1

3.

In this system, Re=528 at 20◦C.

4.

The maximum aspiration rate at the delivery tube/capillary junction should
be below 83μL s-1 to avoid damaging the larvae.

5.

The inner diameter of the input capillary is 800μm

2.6

Electronics
To automate movement of the larvae in the present system, electronic

sensors (e.g. photodiode) and actuators (e.g. syringe pump), were used to control
fish movement through a LabVIEW interface. The myDAQ (National Instruments,
Austin, TX) was used to detect events and to control devices, such as the SC5
solenoid controller (RW Automations, Figure 10) used to control the solenoid valves.
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Figure 10: Electronic Components. RW Automation SC5 Solenoid Controller board
equipped with power, communication, and status LEDs (Left); National Instruments
myDAQ (Right)
The myDAQ from National Instruments (NI) is a Data Acquisition (DAQ) unit
that interfaces with the graphical programming software package, LabView, and
allows for simple external control of connected devices. NI myDAQ is a simple and
intuitive DAQ device with analog inputs, analog outputs, digital inputs and digital
outputs. The digital output channels are used to control the Transistor-Transistor
Logic commands (TTL) that trigger the solenoid pinch valves. The myDAQ was also
be used as a power supply.
The RW Automation SC5 solenoid controller permitted programmable
control of the solenoid pinch valve depicted in Figure 11. The board controls five
independent valves by utilizing a peak-and-hold algorithm. This allows the user to
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energize each solenoid valve at its full rated voltage for fast actuation and strong
pull. The SC5 then automatically reduces the average voltage applied to the solenoid
to conserve power and prevent overheating of the solenoid in the open/on position.

Figure 11: Cole-Parmer two-way normally closed solenoid pinch valve. 12 VDC, 1/16"
ID x 1/8" OD tubing. The solenoid controlled pinch valve clamps with a force of 15 PSI
with a 25 msec response time.
When triggered, the solenoid controller applies 12V to the solenoid valves for
0.5 sec, then reduces the voltage to a holding level of ~4.5V. This minimizes
overheating of the solenoid. The SC5 controller is under TTL control and opens or
closes the solenoid pinch valves with high or low voltage signals from the DIO
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channels of the myDAQ controller. Low to high voltage TTL input transitions trigger
the solenoid valve opening, while high to low TTL voltage transitions turn off the
solenoid voltage to disable the solenoid and close the valve (NC state). TTL inputs of
the solenoid controller board are interfaced with DIO ports 0-4 on the myDAQ and
controlled by a LabView VI with Boolean controls.
To enhance the clarity of data and to permit higher data acquisition rates
from the optical detection system, a precision high-speed voltage comparator was
used (Texas Instruments LM 339N) to convert the photodiode voltage output to a
TTL signal. The voltage comparator functions by comparing the differential voltage
between the positive pin (sporadic voltage from PD) and negative pin (stable
predetermined voltage from myDAQ), then generating a TTL signal based on the
input differential polarity Figure 12.1. This circuit renders the system less sensitive
to potential false readings from the PD.
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Figure 12: Image of the functional circuit diagram. Voltage comparator (left); wiring
of comparator on a breadboard (Right)
The LM339N series IC consists of four independent precision voltage
comparators with an offset voltage specification as low as 2 mV maximum for all
four comparators. The comparator is devised to operate from a single power supply
over a wide range of voltages and to directly interface with TTL (TransistorTransistor Logic) and CMOS (Complementary Metal–Oxide–Semiconductor).

2.6.1 Control Maps/Software Programming
Most of the system is managed manually through a virtual instrument
dashboard designed in LabView, Figure 13. The platform allows automation of the
solenoid valves and the syringe pump to aspirate zebrafish larvae into the
entrapment dock.
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Figure 13: LabVIEW control dashboard. It controls the automation parameters such as
the duration of injection; solenoid on/off commands and syringe pump functions
(pump/withdraw).

43

LabView Test Setup Routine
The following is the data flow diagram for the LabView routine, which
controls the coordinated functions of the syringe pump, the pinch valves and the
optical detection system.

Figure 14: Valve/syringe pump control map
All the solenoid valves are normally closed. A cycle begins with the opening
of valve 1 and valve 3. The syringe pump starts withdrawing at a given flow rate
until a larva is picked up from reservoir 1, conducted through the tube and detected
by the optical detection system. The syringe pump immediately stops withdrawing
and valve 1 and valve 3 close. Next, valve 2 and valve 3 open, followed by the
syringe pump, in infuse mode, aspirating the larva at the set flow rate to the
entrapment dock. Valve 2 closes to prevent backflow. Injection takes place. Valve 4
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and valve 5 open after injection. Syringe pump 2, in infuse mode, flushes the larva
out of the entire system.
The detailed setup and program commands are highlighted in the appendix.
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CHAPTER 3
EXPERIMENTAL RESULTS AND DISCUSSION

3.1

Input Reservoir Efficacy Test
To evaluate the specimen output rate of the reservoir, a system test was

conducted.

3.1.1 Procedure
The reservoir was filled to capacity (60mL) with egg water (60µg/mL) at
room temperature (21°C), Figure 4.1. The bubbler was then turned on to prevent
settling, thereby increasing the likelihood of larva uptake into the system. 50
individual zebrafish larvae were then introduced into the reservoir. The zebrafish
were anesthetized with a 200µg/mL solution of tricaine before use. With the larvae
floating freely within the reservoir, the aspiration tube was lowered into the
chamber and the syringe pump was set to withdraw mode at the following flow
rates for 60 seconds: 10mL/min, 8mL/min, 6mL/min and 4mL/min. The number of
larvae aspirated from the reservoir was then recorded and the entire procedure was
repeated 10 times, consecutively.

3.1.2 Results
For the entrapment system to be more efficient than the traditional injection
method, the reservoir should expel the larvae from the system at a base rate of 3 fish
per minute. The test of the reservoir at the highest flow rate (10mL/min) generated
an average output of about 6 larvae per minute Figure 15. This translates to 1 larva
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output every 10 seconds, which is a relatively shorter duration than the remaining
time it takes a larva to complete the rest of the cycle. This implies that the reservoir
must have an output rate high enough to support the entire system. In spite of the
high output rate, only one larva can be processed by the system for any given cycle.
The high output rate of the reservoir suggests that it has the capacity to feed
multiple entrapment systems simultaneously.
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Figure 15: A bar graph depicting the number of zebrafish larvae collected after 60 sec
at different flow rates.
3.2

Optical Detection Unit Efficacy Test
To evaluate the sensitivity of the optical detection unit, a system test was

conducted routinely.

3.2.1 Procedure
First, the 650nm laser module was powered on, with majority of the light
beam centered on the photodiode (PD). At this point the LabView software,
registered a basal high TTL signal (1,TRUE). Ten individual zebrafish larvae
(~48hpf) were then fed through the tube, past the laser/PD, at 10 mL/min. The
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decrease in light detected by the PD resulted in a low TTL signal (0,FALSE) from the
comparator as the larva passed between the laser and the photodiode and was
monitored by the control software.

3.2.2 Results
The results from sensor tests proved that the light detection system
effectively detected larvae. The waveform graph, Figure 16, displays 10 individual
peaks that correspond to the 10-zebrafish specimens used in this test. The initial
voltage reading (without a comparator circuit) from 7-14 seconds indicates the
observed voltage before water or zebrafish larvae were introduced into the tube.
The background noise apparent in several positions on the chart (ex. 14-25
seconds) can be attributed to air bubbles. The control software traces the recorded
voltage readings that registered below the basal reading (tube+water+specimen),
thus allowing us to discern background noise from useful data.
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Figure 16: A waveform chart of the photodiode voltage spikes with respect to time. The
base reading from the PD is 1V. The rest of the labeled peaks registering sub-basal
voltages indicate the presence of a zebrafish specimen. The comparator circuit was
not used to condition these raw voltage signals.
3.3

Entrapment Dock Tests
The entrapment dock is the main part of the system with the core function of

immobilizing 48-72hpf zebrafish to allow tail injection. A series of test trials were
conducted to assess its ability to entrap and immobilize 48-72hpf zebrafish.

3.3.1 Procedure
To test its ability to accomplish trapping, individual 72hpf zebrafish were
introduced into the dock via the inlet channel and subsequently flushed out. For
every trial that was conducted (n=100), the larva was successfully immobilized
regardless of orientation (head/tail entry) as illustrated in Figure 17.
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Figure 17: Image of the entrapment dock illustrating the immobilized zebrafish larvae
in the two possible orientations. Head-on arrival (left image) and tail arrival (right
image)
3.4

Average Duration of Screening Steps (1 Cycle)

The overall duration for one cycle through the system was determined in this test.

3.4.1 Procedure
By timing each automated stage of the processes (loading, trapping, injection
and flushing) within one cycle, the average cycle time was calculated. Since the flow
rate is varied at certain stages within a given cycle, timing each step provides a more
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accurate projection of the overall duration of one cycle.
Step

Flow Rate (mL/min)

Time (sec)

Reservoir → PD

10mL/min

9±6.5

Reservoir → PD

8.0mL/min

10±10.4

Reservoir → PD

6.0mL/min

13±19.5

Reservoir → PD

4.0mL/min

16±15.3

Table 1: Average duration of screening steps from the reservoir to the light detector at
different flow rates. (0.08cm inner diameter and 88cm length)
Step

Flow Rate (mL/min)

Time (sec)

PD → Entrapment Dock

2mL/min

12

PD → Entrapment Dock

1.75mL/min

14

PD → Entrapment Dock

1.50mL/min

16

PD → Entrapment Dock

1.25mL/min

19

Table 2: Calculated duration of screening steps from the photo-detector to the
entrapment dock at different flow rates. (0.08cm inner diameter and 80cm length)
Step
Time (sec)
Injection procedure
User dependent: 10±3
Table 3: Average time required for injection
Step
5mL/min 4mL/min
3mL/min 2mL/min
Entrapment Dock → Exit
4
5
6
9
Table 4: Calculated duration of screening steps from the entrapment dock to the exit
(of the entire system) at different flow rates. (0.08cm inner diameter and 62cm length)
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3.5

Quantitative Assessment of Animal Health
The condition of each individual zebrafish was assessed after it passed

through the system. This assessment was based on both functional and
morphological criteria. At all flow rates (2mL/min, 1.75mL/min, 1.5mL/min,
1.2mL/min), heartbeat, touch-response, structural integrity of the yolk sac and
melanocytes, were evaluated and compared to a control sample. The larvae in the
control setup (same age) were aspirated in an unobstructed tube spanning the
length of travel encountered by larvae in the experimental setup.

3.5.1 Procedure
The zebrafish from the tests described in section 3.4 were collected and
viewed under a microscope to evaluate the following parameters: survival
(heartbeat) and morphology (structural integrity of the yolk sac and melanocytes).
The following data were recorded in Figure 18.

3.5.2 Results
At all of the flow rates used, 100% of the larvae survived (n=100) for at least.
Tearing of the yolk sac was never observed. At the highest initial flow rate of
2mL/min, 48% of the larvae exhibited morphological abnormalities, specifically
slight distortion of melanocytes along the tail and of the yolk extension, Figure 18.
With the slightly slower initial aspiration rates of 1.75mL/min, all health criteria
matched those of the controls.
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Figure 18: Comparison of morphological abnormalities of experimental zebrafish, at
different flow rates, with a control zebrafish. The red arrows show distortions of the
melanocytes and the highlighted region shows distortions of the eye and the yolk.
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Figure 19: Quantitative assessment of zebrafish health at different flow rates (n=100)
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CHAPTER 4
SUMMARY, CONCLUSIONS AND FUTURE WORK
4.1

Summary
A device to accelerate experiments involving microinjection of large numbers

of larvae was designed and fabricated using inexpensive rapid prototyping
techniques. Chapter 1 introduces the influenza A virus and describes important
aspects of the virus, including its genetics, distribution, transmission and clinical
symptoms of the disease that it causes. This chapter also places emphasis on current
IAV research advancements and reviews the use of animal models for infectious
disease research. Chapter 2 describes the device components separately and
reviews prototyping methods, modes of device function and supporting control
software. The device specifications and parameters are also highlighted in this
chapter. Chapter 3 presents efficacy tests of the main components of the system.

4.2

Conclusions
A fully functional zebrafish immobilization device was designed, fabricated,

and tested. 48-72 hpf zebrafish larvae were successfully immobilized within a 3D
printed dock. The experimental test setup allowed manipulation of the volumetric
flow rate within the tubes, pressure from the air compressor used to create air
bubbles in reservoir 1, voltage within the optical detection system and the overall
device output frequency. The loading stage was improved with the addition of the
bubbler to reservoir 1. This played a major role in distributing larvae evenly within
the chamber during operation.
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Automation of the system enhanced test reproducibility by reducing the
chances for human error. The optical detection system proved effective (see
waveform chart, Figure 16. Individual larvae were successfully identified by the
detection system with 100% precision (no false positives). The control software
traced the recorded voltage readings that registered below the basal reading;
moreover, the comparator increased the data acquisition rate two-fold, from 62 Hz
to 124 Hz.
One of the most challenging aspects of the project was the fabrication of the
immobilization dock. The 3D printer that was used for this project deposited
support material within the channels and no method used to remove the material
was successful. By developing the split design technique, I eliminated this problem
by exposing the channels for simplified post-print processing. The tests of the
entrapment dock were successful, i.e. after running 100 cycles through the dock at
various flow rates: 48% of larvae (n=25) were immobilized without any
deformation at 2mL/min, 76% of larvae (n=25) were immobilized without any
deformation at 1.75mL/min, 100% of larvae (n=25) were immobilized without any
deformation at 1.50mL/min, 100% of larvae (n=25) were immobilized without any
deformation at 1.25mL/min.

4.3

Future Work
At this stage of device development, adjusting the flow rate within the system

during certain parts of a given cycle can alter the frequency of the device’s output. In
spite of the automation incorporated into the device, the user must manually trigger
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the control program to execute certain commands such as when to inject the
specimen. By adding a minimal number of steps to the existing control program, an
automatic injector equipped with a translation stage could be incorporated into the
design to reduce the need for manual input. Furthermore, a recovery system could
easily integrated toward the end of the device to receive the injected larvae after
ejection from the system. Ultimately, the device will provide a seamless user
interface that requires minimal user intervention. By depositing a known number of
zebrafish larvae into the input reservoir, and inputting the dosage of the compound
or chemical under study, the device will be able to inject and dispense larvae for
analysis.
Microsystems designed for cell-based studies or applications such as this one
require fluid handling. Flow within these systems inevitably generates fluid shear
stress that may adversely affect the health of the organisms under study. Simple
assays of specimen viability and morphology were used in this project to detect any
gross disturbances to larval anatomy and physiology. However, it will be beneficial
to specifically evaluate physiological implications of fluid shear stress within the
tubes and the entrapment dock. Varma et al. at Massachusetts Institute of
Technology explored a useful technique that can assist us with understanding the
fluid dynamics within this device. It involves using a genetically encoded cell sensor
that fluoresces in a quantitative fashion upon encountering fluid shear stress
(FSS)98. Varma et al. chose a widely used cell line (NIH3T3s) and created a
transcriptional cell-sensor that fluoresces when transcription of a relevant FSSinduced protein is initiated. The sensor pathway specificity and functionality were
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verified by noting induced fluorescence in response to chemical induction of the FSS
pathway, seen both through microscopy and flow cytometry. In addition, these
novel cell sensors can be induced with a range of FSS intensities and durations, with
a limit of detection of 2 dynes/cm2 when applied for 30 minutes, making it more
versatile in simulating several microfluidic flow conditions. Undertaking the
improvements discussed above will enable for a more seamless operation of this
device and possibly pave the way for subsequent engineering systems with wide
applications in the microsystems community.
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APPENDIX A
ZEBRAFISH HUSBANDRY
Zebrafish were housed at the University of Maine Zebrafish Facility in
recirculating systems where the water temperature was maintained at 28°C with a
total system flow rate of 150 liters/min. Zebrafish were maintained in accordance
with the Institutional Animal Care and Use Committee standards of the University of
Maine. Fertilized zebrafish eggs are collected according to methods proposed by
Phennecie at the University of Maine Zebrafish Facility99. Collected eggs are raised
for 24 hours at 28.0 ̊C in 100mm-diameter petri dishes half full of egg water, 60µg/L
Instant Ocean Salts in purified reverse osmosis water. No more than 100 eggs were
raised in one 100mm-diameter petri dish at a time.
At 24 hours post fertilization, egg water is replaced in each petri dish. Chorions
are removed from the embryos by hand and discarded as biological waste. Live
embryos are stored at 28.0 ̊C until the following day.
At 48hpf, embryos are motile. Egg water is replaced in each petri dish and dead
embryos are removed from the container. Embryos are stored at 28.0 ̊C overnight.
At 72hpf, specimens are considered larvae. Zebrafish egg water is replaced and
specimens are used as needed in further laboratory procedures.
Zebrafish were euthanized in a 600µg/L concentrated stock of Tricane for
30min and fixed to minimize the amount of larvae needed for repeated testing. Fish
are removed from anesthetic and placed in fixative solution of 1.5% gluteraldehyde,
0.5% para-formaldehyde, 50mM PBS (phosphate buffered saline) for long term
storage100. Larvae were fixed for at least 12 hours prior to use. For flow testing,
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chemically fixed fish were removed from fixative solution and placed in egg water
with no more than 0.25% gelatin to minimize larval adhesion to tubing.
For procedures involving live specimens, larvae are anaesthetized in a
200µg/mL solution of tricane with no more than 0.25% gelatin added to minimize
specimen adhesion to tubing. Fish were aspirated through the device in the
anesthetic gelatin solution.
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APPENDIX B
VALVE/SYRINGE PUMP CONTROL MAP
SETUP:
MyDAQ DIO channels (0-5)
•

Input – laser detector (detected fish=1, nothing detected=0)

•

Output – valve 1 (open=1, close=0)

•

Output – valve 2 (open=1, close=0)

•

Output – valve 3 (open=1, close=0)

•

Output – valve 4 (open=1, close=0)

•

Output – valve 5 (open=1, close=0)

•

Output – syringe pump direction (inject=1, withdraw=0)

•

Output – syringe pump start/stop (start=1, stop=0)

Program Commands:
•

All valves closed, pump stopped

•

Set pump to withdraw mode

•

Close valve 2, Close valve 4, Close valve 5(should be closed already)

•

Open valve 1 and valve 3

•

Start pump 1

•

Monitor detector



If positive detect → stop pump, close valve 1, close valve 3, open valve 2,
open valve 3 set pump to inject, start pump

•

Pump injects. Duration: (input value) seconds → stop pump, valve 2 close
73

•

Inject. Duration: (input value) seconds

•

Open valve 4, open valve 5

•

Start pump 2 (infuse)

•

Wait for fish to flush out. Duration: (input value) seconds

•

Stop pump

•

Close valve 5

•

Go to Step 1
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APPENDIX C
MATERIALS LIST
Pump System Materials:


Tygon Micro Bore Tubing, Part #: TGY-030. Component Supply Co.



Silicone Tubing, Part #: SCT-063A. Component Supply Co.



BD 60mL Syringe, Part #: 309654. Becton, Dickinson and Company.



New Era NE-1000X Programmable Syringe Pump



2-way normally closed solenoid pinch valve, Part # 98302. Cole Palmer
Instrument Company, LLC.



Aqua Culture Single Outlet Aquarium Air Pump, Part # 0079285405132
Optical Detection Materials



5mm transparent cylinder head photodiode, Part # LLSO5-A. Senba Optical
Electrical Co., Ltd



4.5V 650 nm red laser diode module, Part # 01444878. LightInTheBox Co.,
Ltd



PROCELL 1.5V dry cell batteries, Part # PC1500. Duracell Inc.

Entrapment Dock Materials


Objet30 Rapid Prototyping System, SUP705 Support Material (Water Jet
Removable). Stratasys Ltd.



Custom Stage Mount



MakerBot Replicator Desktop 3D Printer, PLA Filament. MakerBot Industries,
LLC.
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Electronics


National Instruments myDAQ Unit



SC5 Five-Channel Solenoid Controller/Driver. RW Automations, LLC.



SolidEdge ST7. Siemens Product Lifecycle Management Software Inc.



National Instruments LabVIEW 2016. National Instruments.
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